Table 1.
Comparison of clinical and laboratory parameters between the two groups before transplantation
| Parameter | Control | BM-MNCs | P v1lue |
| Patient (n) | 15 | 32 | ND |
| Age (yr) | 47.4 ± 11.1 | 46.4 ± 11.6 | 0.8542 |
| Gender | |||
| Male | 9 | 20 | |
| Female | 6 | 12 | 0.8691 |
| HBsAg | |||
| Positive | 13 | 30 | |
| Negative | 2 | 2 | 0.5833 |
| Liver function | |||
| Alanine aminotransferase (IU/L) | 51.7 ± 14.5 | 53.2 ± 13.5 | 0.7342 |
| Aspartate aminotransferase (IU/L) | 63.7 ± 14.4 | 67.9 ± 16.7 | 0.4042 |
| Serum albumin (g/L) | 28.1 ± 2.8 | 27.9 ± 2.5 | 0.7962 |
| Prealbumin (mg/L) | 85.1 ± 23.5 | 83.5 ± 22.4 | 0.8192 |
| Total bilirubin (mmol/L) | 53.5 ± 17.9 | 52.2 ± 13.4 | 0.7722 |
| Coagulation function | |||
| Prothrombin time (s) | 16.3 ± 3.0 | 16.9 ± 2.3 | 0.4372 |
| Prothrombin activity | 71.8% ± 19.4% | 67.8% ± 15.0% | 0.4372 |
| Fibrinogen (g/L) | 1.83 ± 0.53 | 1.81 ± 0.52 | 0.8642 |
| Routine blood indices | |||
| White blood cell counts (× 109/L) | 2.83 ± 1.07 | 2.73 ± 0.84 | 0.7212 |
| Hemoglobin (g/L) | 107.8 ± 11.4 | 105.9 ± 12.6 | 0.6242 |
| Platelet counts (× 109/L) | 69.0 ± 16.6 | 67.2 ± 15.5 | 0.7172 |
Data are expressed as the mean ± SD.
1
Pearson χ2 test;
2
t test;
3
Fisher’s exact test. BM-MNCs: Bone marrow mononuclear cells; HBsAg: Hepatitis B surface antigen; ND: No data.